Press Releases
Stay Informed with the Latest Updates from EpiMedTech Global
Discover the cutting-edge advancements and impactful collaborations that drive our mission to revolutionize healthcare through epigenetics. Explore our latest press releases and stay up-to-date with our journey toward transforming global health.
EpiMedtech Global Announces FDA Registration of EPIAGE, the First Epigenetic Age Test Registered by the FDA
November 18, 2024 – Singapore – EpiMedtech Global, a leader in genetic and epigenetic testing, is proud to announce that EPIAGE, an epigenetic test for measuring biological age, has been
EpiMedTech Global Validates Unique epiCervix HPV Combo Test for Cervical Cancer Detection
Singapore, November 18 2024 — EpiMedTech Global Singapore is thrilled to announce the successful validation of our groundbreaking Epicervix HPV combo test, now certified for CLIA and CAP. This innovative
HKG epiTherapeutics’ MetaGen Genetic Risk Assessment Test Receives FDA Registration, Now Available in the U.S.
FOR IMMEDIATE RELEASE Singapore – October 31, 2024 – Epi Med Tech Global, a pioneer in genetic and epigenetic testing, is thrilled to announce the FDA registration of its MetaGen
EpiMedTech Global Launches epiGeneComplete: A Breakthrough Genetic and Epigenetic Test for Comprehensive Health Diagnostics
FOR IMMEDIATE RELEASE Revolutionizing the early detection of health risks through cutting-edge DNA methylation and genetic analysis. Singapore, 2024-10-30 – EpiMedTech Global is proud to announce the launch of epiGeneComplete,
Enhanced Early Detection of Liver Cancer
EpiMedTech Global, a biotech company developing early disease detection tests, announced today the validation of its new test for early liver cancer detection in the peer-reviewed journal Communications Medicine, part
EpiMedTech Global to Present at the 150th National Investment Banking Association Conference Slated for September 4-5 in Ft. Lauderdale
Singapore – News File Corp. – August 27, 2024 – EpiMedTech Global, a company focused on revolutionizing healthcare through real-world applications for early disease detection, today announced that the company
